
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel‐Mediated Reprogramming of Cancer‐Associated Fibroblasts in Osteosarcoma
Hui Wang, Yu Chen, Ran Wei, et al.
Advanced Materials (2023) Vol. 36, Iss. 15
Closed Access | Times Cited: 27
Hui Wang, Yu Chen, Ran Wei, et al.
Advanced Materials (2023) Vol. 36, Iss. 15
Closed Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Zhongsong Zhang, Long Chen
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Zhongsong Zhang, Long Chen
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 12
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 12
Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy
Chunbao Zang, Yu Tian, Yujing Tang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Chunbao Zang, Yu Tian, Yujing Tang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
A 10-year bibliometric analysis in the field of osteosarcoma treatment from 2014 to 2023
Yiguo Shen, Xiao-Bo Shao, Jiansong Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Yiguo Shen, Xiao-Bo Shao, Jiansong Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Hydrogen Therapy Reverses Cancer‐Associated Fibroblasts Phenotypes and Remodels Stromal Microenvironment to Stimulate Systematic Anti‐Tumor Immunity
Xiaoyan Meng, Zhonglong Liu, Liang Deng, et al.
Advanced Science (2024) Vol. 11, Iss. 28
Open Access | Times Cited: 7
Xiaoyan Meng, Zhonglong Liu, Liang Deng, et al.
Advanced Science (2024) Vol. 11, Iss. 28
Open Access | Times Cited: 7
CAFs and T cells interplay: The emergence of a new arena in cancer combat
Minjie Chen, Fei Chen, Zhaofeng Gao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117045-117045
Open Access | Times Cited: 4
Minjie Chen, Fei Chen, Zhaofeng Gao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117045-117045
Open Access | Times Cited: 4
Liposomes-enabled cancer chemoimmunotherapy
Lele Zhang, Jiangpei Shi, Mao‐Hua Zhu, et al.
Biomaterials (2024) Vol. 313, pp. 122801-122801
Closed Access | Times Cited: 4
Lele Zhang, Jiangpei Shi, Mao‐Hua Zhu, et al.
Biomaterials (2024) Vol. 313, pp. 122801-122801
Closed Access | Times Cited: 4
TME-responsive nanocomposite hydrogel with targeted capacity for enhanced synergistic chemoimmunotherapy of MYC-amplified osteosarcoma
Yichao Ma, Lai Peng, Zhou Sha, et al.
Bioactive Materials (2025) Vol. 47, pp. 83-99
Closed Access
Yichao Ma, Lai Peng, Zhou Sha, et al.
Bioactive Materials (2025) Vol. 47, pp. 83-99
Closed Access
NGR‐Modified CAF‐Derived exos Targeting Tumor Vasculature to Induce Ferroptosis and Overcome Chemoresistance in Osteosarcoma
Jianxin Du, Xiangwei Meng, Minghao Yang, et al.
Advanced Science (2025)
Open Access
Jianxin Du, Xiangwei Meng, Minghao Yang, et al.
Advanced Science (2025)
Open Access
Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
Yunxiang Hu, Rui Yang, Shuai Ni, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Yunxiang Hu, Rui Yang, Shuai Ni, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Intraductal chemotherapy for triple-negative breast cancer: a pathway to minimally invasive clinical treatment
Xinhong Wu, Yuan Feng, Liantao Guo, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Xinhong Wu, Yuan Feng, Liantao Guo, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Association between cancer-associated fibroblasts and prognosis of neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma: a bioinformatics analysis based on single-cell RNA sequencing
Zhao Huang, Zhuang‐Zhuang Cong, Jing Luo, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Zhao Huang, Zhuang‐Zhuang Cong, Jing Luo, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis
Linghui Zou, Peng Xian, Qing Pu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Linghui Zou, Peng Xian, Qing Pu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Construction of In Situ Personalized Cancer Vaccines by Bioorthogonal Catalytic Microneedles for Augmented Melanoma Immunotherapy
Qianhe Xu, Xiu‐Yuan Yin, Z. Chen, et al.
Small (2025)
Closed Access
Qianhe Xu, Xiu‐Yuan Yin, Z. Chen, et al.
Small (2025)
Closed Access
FePS3-Nanosheets-Integrated multifunctional nanocomposite hydrogel for multimodal synergistic osteosarcoma therapy and enhanced bone regeneration
Bing Ye, Xirui Jing, Yanlin Su, et al.
Chemical Engineering Journal (2025), pp. 162175-162175
Closed Access
Bing Ye, Xirui Jing, Yanlin Su, et al.
Chemical Engineering Journal (2025), pp. 162175-162175
Closed Access
Chemoimmunotherapy synergism: mechanisms and clinical applications
Rahaman Shaik, Sai Manasa Chittepu, Meghana Tarapatla, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Rahaman Shaik, Sai Manasa Chittepu, Meghana Tarapatla, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
Jianghu Zhou, Fengjun Lan, Miao Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Jianghu Zhou, Fengjun Lan, Miao Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Development of Injectable Thermosensitive Nanocomposite Hydrogel for Ratiometric Drug Delivery to Treat Drug Resistant Chondrosarcoma In Vivo
Jiahui Zhu, Ran Wei, Guang Hu, et al.
Small (2024) Vol. 20, Iss. 31
Closed Access | Times Cited: 4
Jiahui Zhu, Ran Wei, Guang Hu, et al.
Small (2024) Vol. 20, Iss. 31
Closed Access | Times Cited: 4
Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy
Meng-Ru Zhang, Linlin Fang, Yang Guo, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3387-3404
Open Access | Times Cited: 3
Meng-Ru Zhang, Linlin Fang, Yang Guo, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3387-3404
Open Access | Times Cited: 3
Hybrid Nanogel Drug Delivery Systems: Transforming the Tumor Microenvironment through Tumor Tissue Editing
Theodora Katopodi, Savvas Petanidis, George Floros, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 908-908
Open Access | Times Cited: 3
Theodora Katopodi, Savvas Petanidis, George Floros, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 908-908
Open Access | Times Cited: 3
System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy
Zhouwei Wu, Jiapei Yu, Tao Han, et al.
BMC Musculoskeletal Disorders (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Zhouwei Wu, Jiapei Yu, Tao Han, et al.
BMC Musculoskeletal Disorders (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
NIR‐II AIEgens nanosystem for fluorescence and chemiluminescence synergistic imaging‐guided precise resection in osteosarcoma surgery
Ruotong Li, Kaiyuan Liu, Qian Hu, et al.
Aggregate (2024)
Open Access | Times Cited: 2
Ruotong Li, Kaiyuan Liu, Qian Hu, et al.
Aggregate (2024)
Open Access | Times Cited: 2
Recent advances in nanoagents delivery system-based phototherapy for osteosarcoma treatment
Lichen Ji, Jiaqing Huang, Liting Yu, et al.
International Journal of Pharmaceutics (2024) Vol. 665, pp. 124633-124633
Closed Access | Times Cited: 1
Lichen Ji, Jiaqing Huang, Liting Yu, et al.
International Journal of Pharmaceutics (2024) Vol. 665, pp. 124633-124633
Closed Access | Times Cited: 1
Advancing Ovarian Cancer Therapeutics: The Role of Targeted Drug Delivery Systems
Qianhan Lin, Jiajia Li, Zulimire Abudousalamu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9351-9370
Open Access
Qianhan Lin, Jiajia Li, Zulimire Abudousalamu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9351-9370
Open Access
Liposome-like Nanoplatform Regulates Autophagy to Enhance Antitumor Chemo-Immunotherapy
Haojun Li, Ling Mei, Yuxin Xie, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 22, pp. 25447-25458
Closed Access
Haojun Li, Ling Mei, Yuxin Xie, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 22, pp. 25447-25458
Closed Access